ACE-inhibitors but not endothelin receptor blockers prevent podocyte loss in early diabetic nephropathy

AbstractAims/hypothesis  It was the aim of our study to investigate the influence of a selective ET-A receptor antagonist LU 135252 alone and in combination with the ACE-inhibitor, trandolapril on podocyte number and morphology in streptozotocin